Premium
In Vivo Optical Imaging of Amyloid Aggregates in Brain: Design of Fluorescent Markers
Author(s) -
Nesterov Evgueni E.,
Skoch Jesse,
Hyman Bradley T.,
Klunk William E.,
Bacskai Brian J.,
Swager Timothy M.
Publication year - 2005
Publication title -
angewandte chemie international edition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.831
H-Index - 550
eISSN - 1521-3773
pISSN - 1433-7851
DOI - 10.1002/anie.200500845
Subject(s) - in vivo , amyloid (mycology) , optical imaging , amyloid β , neuroscience , biomarker , rational design , brain tissue , fluorescence , computer science , neuroimaging , pathology , chemistry , medicine , disease , nanotechnology , biology , biochemistry , materials science , microbiology and biotechnology , optics , physics
Routine diagnostics and studies of Alzheimer's disease might benefit form the noninvasive optical imaging of amyloid‐β plaques in the brain. A rational design strategy for in vivo amyloid‐imaging agents that enter the brain and selectively stain amyloid plaques is presented (see picture), and properties of a promising lead biomarker candidate are reported.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom